SCHEMBL5162379

SCHEMBL5162379

Cc1nc(-c2cccnc2)sc1-c1ccnc(NC2=COCO2)n1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 3/20 0.45
BCR P11274 2/20 0.45
CDK2 P24941 16/20 0.44
CDK4 P11802 13/20 0.44
AURKA O14965 4/20 0.43
CDK1 P06493 4/20 0.43
CDK9 P50750 4/20 0.43
CDK7 P50613 3/20 0.43
AURKB Q96GD4 3/20 0.43
PRKCA P17252 2/20 0.42
EGFR P00533 1/20 0.42
PRKCD Q05655 1/20 0.42
PLK1 P53350 2/20 0.41
CCNA2 P20248 2/20 0.41
CCNT1 O60563 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNH P51946 1/20 0.40
CCNA1 P78396 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5162399 0.83 CDK2 (0.44) ABL1BCRCDK2CDK4AURKA
SCHEMBL27720404 0.81 CDK2 (0.67) ABL1BCRCDK2CDK4AURKA
SCHEMBL4157090 0.81 CLK1 (0.57) ABL1BCRCDK2CDK4AURKA
SCHEMBL12278950 0.81 CDK2 (0.51) ABL1BCRCDK2CDK4AURKA
SCHEMBL4164507 0.79 CDK4 (0.52) ABL1BCRCDK2CDK4AURKA
SCHEMBL6156440 0.79 CDK2 (0.67) ABL1BCRCDK2CDK4AURKA
SCHEMBL5164206 0.78 CDK2 (0.59) ABL1CDK2CDK4AURKACDK1
SCHEMBL4173509 0.77 CDK2 (0.71) ABL1BCRCDK2CDK4AURKA
SCHEMBL4164771 0.77 ZAP70 (0.54) ABL1BCRCDK2CDK4AURKA
SCHEMBL4176513 0.76 CDK2 (0.60) ABL1BCRCDK2CDK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756098-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2007-02-28 EP disclosed
WO-2005116025-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2005-12-08 WO disclosed